Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-017228
Filing Date
2022-08-15
Accepted
2022-08-15 07:37:37
Documents
79
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q grna-20220630.htm   iXBRL 10-Q 3314014
2 EX-31.1 grna-ex31_1.htm EX-31.1 30551
3 EX-31.2 grna-ex31_2.htm EX-31.2 30372
4 EX-32.1 grna-ex32_1.htm EX-32.1 32637
  Complete submission text file 0000950170-22-017228.txt   10379201

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT grna-20220630_cal.xml EX-101.CAL 59390
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT grna-20220630_pre.xml EX-101.PRE 629520
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT grna-20220630_lab.xml EX-101.LAB 650635
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT grna-20220630_def.xml EX-101.DEF 536844
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT grna-20220630.xsd EX-101.SCH 96487
73 EXTRACTED XBRL INSTANCE DOCUMENT grna-20220630_htm.xml XML 1076954
Mailing Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155
Business Address 200 BOSTON AVENUE SUITE 3100 MEDFORD MA 02155 (617) 616-8188
GreenLight Biosciences Holdings, PBC (Filer) CIK: 0001822691 (see all company filings)

EIN.: 851914700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39894 | Film No.: 221162359
SIC: 2836 Biological Products, (No Diagnostic Substances)